Bright Pharma Engineering Private Limted - Due diligence report

A 360° intelligence report on Bright Pharma Engineering Private Limted: trust score, financial health, credit view, compliance, directors, g…

2008-01-04 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
BP Bright Pharma Engineering Private Limted
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Bright Pharma Engineering Private Limted — 360° Intelligence Report

Generated from MCA filings & public records
88/100
Trust Score
Low Risk

Bright Pharma Engineering Private Limted is assessed as Low Risk with a Trust Score of 88/100. Bright Pharma Engineering Private Limted is an active private limited indian non-government company incorporated in 2008, operating in the Machinery and Equipment sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 21 Jul 2026 from the latest processed filings. Bright Pharma Engineering Private Limted snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • Moderate gearing (D/E 38%).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (11.68 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Others1 48.0 cr
Hdfc Bank Limited1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
CHIMANLAL VALLABHRAM PANCHAL 01234567 Director 01/04/2018 6 yrs Approved
SMITA VIJAY PANCHAL 01234567 Director 01/04/2018 6 yrs Approved
DILIP CHIMANLAL PANCHAL 01234567 Director 01/04/2018 6 yrs Approved
VIJAY CHIMANLAL PANCHAL 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 65
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Asset base grew 2.1x - capacity expansion.
Operating for 18+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Outside liabilities up 24% in a year.
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence86/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment78/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 11.68 cr already registered.
  • Compliance record supports lending.
Investor view76/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 9 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
17 Nov 2022
Charge created
Hdfc Bank Limited - 25.08 Lakh
16 Oct 2019
Charge created
Others - 11.42 cr
04 Jan 2008
Incorporated
Registered with Roc Mumbai I
Director appointed
CHIMANLAL VALLABHRAM PANCHAL (Director)
Director appointed
SMITA VIJAY PANCHAL (Director)
Director appointed
DILIP CHIMANLAL PANCHAL (Director)
Director appointed
VIJAY CHIMANLAL PANCHAL (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Chemitek Process Equipments Private Limited U29309GJ2020PTC112810 Valsad, Gujarat, India
Prom Machining Solutions India Private Limited U02919TZ2005PTC011794 Hosur, Tamil Nadu, India
New Era Dairy Engineers (India) Private Limited U15201UP2006PTC031688 Noida, Uttar Pradesh, India
Excel Machinery (Gujarat) Private Limited U29199GJ1995PTC028273 Kalol, Gujarat, India
Transtechnologies Thermal Private Limited U29190WB2001PTC093471 Kolkata, West Bengal, India
Encon Frp Fan Private Limited U74210MH1999PTC117963 Mumbai, Maharashtra, India
Bgi Engitech U29100GJ2010FTC063138 Dascroi, Gujarat, India
Cyclo Transmissions Ltd U40103MH1985PLC035675 Satara, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Bright Pharma Engineering Private Limted before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Bright Pharma Engineering Private Limted: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Bright Pharma Engineering Private Limted - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Bright Pharma Engineering Private Limted pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Bright Pharma Engineering Private Limted - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Bright Pharma Engineering Private Limted an active company?

Bright Pharma Engineering Private Limted has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Bright Pharma Engineering Private Limted financially healthy?

Bright Pharma Engineering Private Limted has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Bright Pharma Engineering Private Limted?

Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Bright Pharma Engineering Private Limted?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Bright Pharma Engineering Private Limted have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Bright Pharma Engineering Private Limted up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Bright Pharma Engineering Private Limted?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.